Drug Costing $9200 Scores Zero on Cancer Doctor Value Scale

Monday, 22 June 2015

BloombergDrug Costing $9200 Scores Zero on Cancer Doctor Value ScaleBloombergThe leading group of U.S. cancer doctors created a scoring system for oncology drugs, awarding a zero for overall benefit to the $9,200-a-month regimen featuring Eli Lilly & Co.'s Alimta. The formula ranges from 0 to 100 points and was published Monday ...and more »